| For: | Yi P, Lu FE, Xu LJ, Chen G, Dong H, Wang KF. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ. World J Gastroenterol 2008; 14(6): 876-883 [PMID: 18240344 DOI: 10.3748/wjg.14.876] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/876.htm |
| Number | Citing Articles |
| 1 |
Li Lu, Huang Zhijian, Li Lei, Chen Wenchuan, Zhu Zhimin. Berberine in Combination with Insulin Has Additive Effects on Titanium Implants Osseointegration in Diabetes Mellitus Rats. Evidence-Based Complementary and Alternative Medicine 2015; 2015 doi: 10.1155/2015/824259
|
| 2 |
Caixia Yang, Guanghong Sui, Lu Wang, Zheng Chen, Feng Wang. MiR-124 Prevents the Microglial Proinflammatory Response by Inhibiting the Activities of TLR4 and Downstream NLRP3 in Palmitic Acid-Treated BV2 Cells. Journal of Molecular Neuroscience 2022; 72(3) doi: 10.1007/s12031-021-01921-8
|
| 3 |
Arrigo F. G. Cicero, Alessandra Baggioni. Anti-inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology 2016; 928 doi: 10.1007/978-3-319-41334-1_2
|
| 4 |
Aru Sun, Haoyu Yang, Tao Li, Jinli Luo, Ling Zhou, Rui Chen, Lin Han, Yiqun Lin. Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1368950
|
| 5 |
Fen Li, Yun-bin Zhao, Ding-kun Wang, Xin Zou, Ke Fang, Kai-fu Wang. Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016; 36(1) doi: 10.1007/s11596-016-1543-5
|
| 6 |
Yueshan Hu, Gareth E. Davies. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia 2010; 81(5) doi: 10.1016/j.fitote.2009.10.010
|
| 7 |
Ying Hu, Jixiong Xu, Jiancheng Wang, Lingyan Zhu, Jiao Wang, Qin Zhang. DPP-4 Inhibitors Suppress Tau Phosphorylation and Promote Neuron Autophagy through the AMPK/mTOR Pathway to Ameliorate Cognitive Dysfunction in Diabetic Mellitus. ACS Chemical Neuroscience 2023; 14(18) doi: 10.1021/acschemneuro.2c00733
|
| 8 |
Shekoufeh Aalinezhad, Farid Dabaghian, Aida Namdari, Maryam Akaberi, Seyed Ahmad Emami. Phytochemistry and pharmacology of alkaloids from Papaver spp.: a structure–activity based study. Phytochemistry Reviews 2025; 24(1) doi: 10.1007/s11101-024-09943-x
|
| 9 |
Hyeon-Jin Kim, Qiang Li, Woo-Jin Song, Hye-Mi Yang, Su-Yeon Kim, Sang-Chul Park, Jin-Ok Ahn, Hwa-Young Youn. Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models. BMC Veterinary Research 2018; 14(1) doi: 10.1186/s12917-018-1671-1
|
| 10 |
Cheng Luo, Hui Yang, Chengyong Tang, Gaoqiong Yao, Lingxi Kong, Haixia He, Yuanda Zhou. Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats. International Immunopharmacology 2015; 28(1) doi: 10.1016/j.intimp.2015.07.018
|
| 11 |
Zheng Li, Ya-Na Geng, Jian-Dong Jiang, Wei-Jia Kong, Yao Tong. Antioxidant and Anti‐Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus. Evidence-Based Complementary and Alternative Medicine 2014; 2014(1) doi: 10.1155/2014/289264
|
| 12 |
Xiaoqing Li, Xinxin Li, Genbei Wang, Yan Xu, Yuanyuan Wang, Ruijia Hao, Xiaohui Ma. Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice. Frontiers of Medicine 2018; 12(6) doi: 10.1007/s11684-018-0662-8
|
| 13 |
Shiwei Liu, Ruixue Duan, Yaru Wu, Fang Du, Jiaxin Zhang, Xin Li, Shenghui Guo, Meimei Wang, Qi Zhang, Yuanbin Li, Naishi Li. Effects of Vaspin on Insulin Resistance in Rats and Underlying Mechanisms. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31923-3
|
| 14 |
Ya-Fei Liu, Huan-Huan Wang, Yin-Hong Geng, Liang Han, Sheng-Hao Tu, Hui Wang. Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1112088
|
| 15 |
Guanghong Sui, Caixia Yang, Lu Wang, Xiangyang Xiong, Mengtian Guo, Zheng Chen, Feng Wang. Exogenous IGF-1 improves tau pathology and neuronal pyroptosis in high-fat diet mice with cognitive dysfunction. Metabolic Brain Disease 2021; 36(7) doi: 10.1007/s11011-021-00787-4
|
| 16 |
Huanguang Xie, Qingqing Wang, Xinyue Zhang, Te Wang, Wei Hu, Theasha Manicum, Hua Chen, Liaojun Sun. Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis. Biomedicine & Pharmacotherapy 2018; 108 doi: 10.1016/j.biopha.2018.08.131
|
| 17 |
Yueshan Hu, Hesham Fahmy, Jordan K. Zjawiony, Gareth E. Davies. Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation. Fitoterapia 2010; 81(4) doi: 10.1016/j.fitote.2009.09.012
|
| 18 |
Yuanli Wang, Wenwen Gong, Shaofang Lv, Hongmei Qu, Yanling He. Berberine improves insulin resistance in adipocyte models by regulating the methylation of hypoxia-inducible factor-3α. Bioscience Reports 2019; 39(10) doi: 10.1042/BSR20192059
|
| 19 |
Yunfeng Li, Yulong Ma, Lei Yao, Jianhua Li, Xunjie Zhou, Mingzhu Wang, Mingtai Gui, Da Li, Xiaozhe Chen, Yidan Dong, Bo Lu, Deyu Fu. A Review of the Mechanisms of Astragaloside IV and Berberine in Vascular Dysfunction Associated with Obesity and Diabetes. Drug Design, Development and Therapy 2025; doi: 10.2147/DDDT.S520323
|
| 20 |
Yung-Tsuan Ho, Jai-Sing Yang, Tsai-Chung Li, Jen-Jyh Lin, Jaung-Geng Lin, Kuang-Chi Lai, Chia-Yu Ma, W. Gibson Wood, Jing-Gung Chung. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and -9. Cancer Letters 2009; 279(2) doi: 10.1016/j.canlet.2009.01.033
|
| 21 |
Arrigo Cicero, Sibel Ertek. Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clinical Lipidology 2009; 4(5) doi: 10.2217/clp.09.41
|
| 22 |
Cong Liu, Zhuo Wang, Yulong Song, Dan Wu, Xuan Zheng, Ping Li, Jin Jin, Nannan Xu, Ling Li. Effects of Berberine on Amelioration of Hyperglycemia and Oxidative Stress in High Glucose and High Fat Diet-Induced Diabetic Hamsters In Vivo. BioMed Research International 2015; 2015 doi: 10.1155/2015/313808
|
| 23 |
Beatrice Scazzocchio, Rosaria Varì, Massimo D'Archivio, Carmela Santangelo, Carmelina Filesi, Claudio Giovannini, Roberta Masella. Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. Journal of Lipid Research 2009; 50(5) doi: 10.1194/jlr.M800402-JLR200
|
| 24 |
Amin Gasmi, Farah Asghar, Saba Zafar, Petro Oliinyk, Oksana Khavrona, Roman Lysiuk, Massimiliano Peana, Salva Piscopo, Halyna Antonyak, Joeri J. Pen, Iryna Lozynska, Sadaf Noor, Larysa Lenchyk, Akram Muhammad, Inna Vladimirova, Natalia Dub, Olha Antoniv, Oksana Tsal, Taras Upyr, Geir Bjørklund. Berberine: Pharmacological Features in Health, Disease and Aging. Current Medicinal Chemistry 2024; 31(10) doi: 10.2174/0929867330666230207112539
|
| 25 |
Wei-Lu Chen, Hen-Wei Wei, Wen-Zan Chiu, Ching-Hui Kang, Ting-Han Lin, Chien-Ching Hung, Ming-Chun Chen, Ming-Song Shieh, Chin-Cheng Lee, Horng-Mo Lee. Metformin regulates hepatic lipid metabolism through activating AMP-activated protein kinase and inducing ATGL in laying hens. European Journal of Pharmacology 2011; 671(1-3) doi: 10.1016/j.ejphar.2011.09.029
|
| 26 |
Dandan Li, Xiaoyang Bi, Jingjing Ma, Xiaohong Zhang, Keni Jiang, Xuezhen Zhu, Jiguang Huang, Lijuan Zhou. Natural herbicidal alkaloid berberine regulates the expression of thalianol and marneral gene clusters in Arabidopsis thaliana. Pest Management Science 2022; 78(7) doi: 10.1002/ps.6914
|
| 27 |
Zeng-si Wang, Fu-er Lu, Li-jun Xu, Hui Dong. Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells. Acta Pharmacologica Sinica 2010; 31(5) doi: 10.1038/aps.2010.30
|
| 28 |
Deanna M Minich, Jeffrey S Bland. Dietary management of the metabolic syndrome beyond macronutrients. Nutrition Reviews 2008; 66(8) doi: 10.1111/j.1753-4887.2008.00075.x
|
| 29 |
Hyun-Jung Park, EunYee Jung, Insop Shim, Stefania Cantore. Berberine for Appetite Suppressant and Prevention of Obesity. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/3891806
|
| 30 |
|
| 31 |
Suriya P. Singh, Koneni V. Sashidhara. Lipid lowering agents of natural origin: An account of some promising chemotypes. European Journal of Medicinal Chemistry 2017; 140 doi: 10.1016/j.ejmech.2017.09.020
|
| 32 |
Giuseppe Derosa, Pamela Maffioli, Arrigo FG Cicero. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opinion on Biological Therapy 2012; 12(8) doi: 10.1517/14712598.2012.704014
|
| 33 |
Seunghee Bae, Younjung Jung, Yeong Choi, Shunhua Li. Effects of Er-Miao-San extracts on TNF-alpha-induced MMP-1 expression in human dermal fibroblasts. Biological Research 2015; 48(1) doi: 10.1186/0717-6287-48-8
|
| 34 |
Yan Yao, Jing Zuo, Li Chen, Yuegang Wei. Combination of metformin and berberine represses the apoptosis of sebocytes in high‐fat diet‐induced diabetic hamsters and an insulin‐treated human cell line. Cell Biochemistry and Function 2020; 38(5) doi: 10.1002/cbf.3504
|
| 35 |
Guo-Sheng Li, Xu-Han Liu, Hua Zhu, Lan Huang, Ya-Li Liu, Chun-Mei Ma, Chuan Qin. Berberine-Improved Visceral White Adipose Tissue Insulin Resistance Associated with Altered Sterol Regulatory Element-Binding Proteins, Liver X Receptors, and Peroxisome Proliferator-Activated Receptors Transcriptional Programs in Diabetic Hamsters. Biological and Pharmaceutical Bulletin 2011; 34(5) doi: 10.1248/bpb.34.644
|
| 36 |
Carmen Spatuzza, Loredana Postiglione, Bianca Covelli, Margherita Ricciardone, Claudio Benvenuti, Paolo Mondola, Anna Belfiore. Effects of berberine and red yeast on proinflammatory cytokines IL-6 and TNF-α in peripheral blood mononuclear cells (PBMCs) of human subjects. Frontiers in Pharmacology 2014; 5 doi: 10.3389/fphar.2014.00230
|
| 37 |
Ji-ping Li, Ye Yuan, Wen-you Zhang, Zhen Jiang, Tian-jiao Hu, Yi-ting Feng, Mo-xiang Liu. Effect of Radix isatidis polysaccharide on alleviating insulin resistance in type 2 diabetes mellitus cells and rats. Journal of Pharmacy and Pharmacology 2019; 71(2) doi: 10.1111/jphp.13023
|
| 38 |
Alexandra Cok, Christina Plaisier, Matthew J. Salie, Daniel S. Oram, Jude Chenge, Larry L. Louters. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie 2011; 93(7) doi: 10.1016/j.biochi.2011.04.013
|
| 39 |
Zhen-hua Dong, Hai-yan Lin, Fu-lian Chen, Xiao-qi Che, Wen-kai Bi, Shu-long Shi, Jing Wang, Ling Gao, Zhao He, Jia-jun Zhao. Berberine improves intralipid-induced insulin resistance in murine. Acta Pharmacologica Sinica 2021; 42(5) doi: 10.1038/s41401-020-0493-4
|
| 40 |
Yichun Xu, Guanglin Xu, Li Liu, Desheng Xu, Jianwen Liu. Anti‐invasion effect of rosmarinic acid via the extracellular signal‐regulated kinase and oxidation–reduction pathway in Ls174‐T cells. Journal of Cellular Biochemistry 2010; 111(2) doi: 10.1002/jcb.22708
|
| 41 |
Arrigo F. G. Cicero, Elisa Tartagni. Antidiabetic Properties of Berberine: From Cellular Pharmacology to Clinical Effects. Hospital Practice 2012; 40(2) doi: 10.3810/hp.2012.04.970
|
| 42 |
Hui Wang, Wei Mu, Hongcai Shang, Jia Lin, Xiang Lei. The Antihyperglycemic Effects of Rhizoma Coptidis and Mechanism of Actions: A Review of Systematic Reviews and Pharmacological Research. BioMed Research International 2014; 2014 doi: 10.1155/2014/798093
|
| 43 |
Min Wu, Jie Wang, Long-tao Liu. Advance of studies on anti-atherosclerosis mechanism of berberine. Chinese Journal of Integrative Medicine 2010; 16(2) doi: 10.1007/s11655-010-0188-7
|
| 44 |
Xueling Ma, Zhongjun Chen, Le Wang, Gesheng Wang, Zihui Wang, XiaoBo Dong, Binyu Wen, Zhichen Zhang. The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00782
|
| 45 |
Yanwen Wang, Tony Campbell, Benjamin Perry, Cécile Beaurepaire, Ling Qin. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 2011; 60(2) doi: 10.1016/j.metabol.2010.02.005
|
| 46 |
Qian Hu, Lingli Li, Xin Zou, Lijun Xu, Ping Yi. Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01150
|
| 47 |
Jinjin Li, Jialin Li, Jiajia Ni, Caibo Zhang, Jianlei Jia, Guoying Wu, Hongzhao Sun, Shuzhen Wang. Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.752512
|
| 48 |
Ming Zhang, Xiao-Yan Lv, Jing Li, Zhi-Gang Xu, Li Chen, Timothy Kern. The Characterization of High‐Fat Diet and Multiple Low‐Dose Streptozotocin Induced Type 2 Diabetes Rat Model. Journal of Diabetes Research 2008; 2008(1) doi: 10.1155/2008/704045
|
| 49 |
Satoshi Fukumitsu, Myra O. Villareal, Shoko Onaga, Kazuhiko Aida, Junkyu Han, Hiroko Isoda. α-Linolenic acid suppresses cholesterol and triacylglycerol biosynthesis pathway by suppressing SREBP-2, SREBP-1a and -1c expression. Cytotechnology 2013; 65(6) doi: 10.1007/s10616-012-9510-x
|